Use of Magnetic Resonance Imaging to Assess Myocardial Perfusion after Transmyocardial Laser Revascularization
Background: Transmyocardial laser revascularization (TMLR) is an alternative treatment modality for patients with refractory angina who are not candidates for conventional surgical or percutaneous revascularization. Clinical studies of TMLR have not shown one-to-one correlation between increased myocardial perfusion and improved clinical status.
Methods: Three patients (51, 53, and 70 years old) with severe, diffuse coronary artery disease not amenable to conventional surgical revascularization and with angina (Canadian Cardiovascular Society [CCS] class 3-4) refractory to maximal medical therapy underwent TMLR with a CO2 laser. Preoperative and postoperative cardiac magnetic resonance imaging (MRI) were performed to assess left ventricular perfusion and wall-motion changes in the laser-treated areas. Postoperative MRIs were performed within 6 months of TMLR and at 12 months. Angina status was assessed with the Seattle Angina Questionnaire.
Results: Postoperative adenosine stress myocardial perfusion imaging with MRI revealed improved overall perfusion and a reduction in subendocardial hypoperfused areas when compared to preoperative images. In all patients, an improvement in CCS class was consistent with an improvement in perfusion.
Conclusions: Cardiac MRI can be used to assess improved subendocardial perfusion after TMLR treatment. In our study, we found that endocardial perfusion was maintained over a 12-month period.
Allen KB, Dowling RB, Fudge TL, et al. 1999. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 341:1029-36.nAllen KB, Dowling RD, Heimansohn DA, et al. 2003. Transmyocardial revascularization versus medical therapy: five-year follow-up of a prospective randomized trial. Heart Surg Forum 6(Supp 1):S15.nFrazier OH, Cooley DA, Kadipasaoglu KA, et al. 1995. Myocardial revascularization with laser: preliminary findings. Circulation 92(9 Suppl):II58-65.nFrazier OH, March RJ, Horvath KA. 1999. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 341:1021-8.nGebker R, Schwitter, Fleck E, Nagel E. 2007. How we perform myocardial perfusion with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 9:539-47.nHattler BG, Griffith BP, Zenati MA, et al. 1999. Transmyocardial laser revascularization in the patient with unmanageable unstable angina. Ann Thorac Surg 68:1203-9.nHorvath KA, Cohn LH, Cooley DA, et al. 1997. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 113:645-54.nHorvath KA, Aranki SF, Cohn LH, et al. 2001. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser. Circulation 104(12 Suppl 1):I81-4.nKadipasaoglu KA, Frazier OH. 1999. Transmyocardial laser revascularization: effect of laser parameters on tissue ablation and cardiac perfusion. Semin Thorac Cardiovasc Surg 11:4-11.nKwong KF, Schuessler RB, Kanellopoulos GK, Saffitz JE, Sundt TM 3rd. 1998. Nontransmural laser treatment incompletely denervates canine myocardium. Circulation 98(19 Suppl):II67-72.nMartin ET, Fuisz AR, Pohost GM. 1998. Imaging cardiac structure and pump function. Cardiol Clin 16:135-60.nOkada M, Ikuta H, Shimizu K, Horii H, Nakamura K. 1986. Alternative method of myocardial revascularization by laser: experimental and clinical study. Kobe J Med Sci 32:151-61.nRimoldi O, Burns SM, Rosen SD, et al. 1999. Measurement of myocardial blood flow with positron emission tomography before and after transmyocardial laser revascularization. Circulation 100(19 Suppl):II134-8.nSchofield PM, Sharples LD, Caine N, et al. 1999. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet 353::519-24.nSchwitter J. 2006. Myocardial Perfusion. J Magn Reson Imaging 24:953-63.nSpanier T, Smith CR, Burkhoff D. 1997. Angiogenesis: a possible mechanism underlying the clinical benefits of transmyocardial laser revascularization. J Clin Laser Med Surg 15:269-73.nvan der Sloot JA, Huikeshoven M, Tukkie R, et al. 2004. Transmyocardial revascularization using an XeCl excimer laser: results of a randomized trial. Ann Thorac Surg 78:875-81.nWilke N, Jerosch-Herold M. 1998. Assessing myocardial perfusion in coronary artery disease with magnetic resonance first-pass imaging. Cardiol Clin 16:227-46.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).